Findings from a new study published in The Clinical Journal of the American Society of Nephrology, involving a collaborative effort between researchers at Dartmouth's Geisel School of Medicine, Vanderbilt, and Veteran's Affairs ...
Jan 19, 2023
0
6
A new study argues that expanding health insurance coverage can drive medical progress, support well-being, and even extend lifespan in the United States.
Jan 13, 2023
0
25
A recent study discovered a novel therapeutic target named ADAM10 that could be used to treat patients with Diabetic Retinopathy (DR), a condition that leads to blindness induced by prolonged diabetes. Abnormal blood vessel ...
Dec 22, 2022
0
39
Globalization has significantly improved access to quality health care but some patients in developing countries are getting too much of it, researchers say.
Nov 4, 2022
0
3
Access to quality health care is a fundamental human right. Yet more than half the world's population can't obtain even the most essential health care. Out-of-pocket costs drive hundreds of millions into extreme poverty
Nov 2, 2022
0
3
Malaria is an infection of red blood cells and is caused by parasites that are transferred to humans by mosquitoes. If left untreated, it can be fatal. In 2020 alone, nearly half the globe's population was at risk of being ...
Sep 20, 2022
0
53
Multiple system atrophy (MSA) is a neurodegenerative disorder characterized by the aggregation of α-synuclein in the brain. Now, scientists from Japan, in collaboration with three pharmaceutical companies, have developed ...
Aug 30, 2022
0
104
Researchers at the University of Colorado Anschutz Medical Campus have investigated how antiviral proteins called interferons interact with SARS-CoV-2, the cause of COVID-19. The study, published in Proceedings of the National ...
Jul 25, 2022
0
138
The percentage of methadone-involved overdose deaths relative to all drug overdose deaths declined from January 2019 to August 2021, according to a new study. Access to methadone, a medication to treat opioid use disorder, ...
Jul 13, 2022
0
8
A Phase II clinical trial of poziotinib for non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) exon 20 mutations, led by researchers at The University of Texas MD Anderson Cancer Center, found ...
Jul 11, 2022
0
6
